Meet the cancer scientists on our Medical Research Advisory Committee

Each of our Medical Research Advisory Committee members are cancer scientists of the highest national and, in many cases, global repute. These cancer scientists are leaders in Australian cancer research and consider all applications received for ACRF grants funding, making recommendations to the Board of Trustees of ACRF as to where grants could be awarded for maximum impact and innovation in cancer prevention, diagnosis and cure.

Procedures of the Committee include assessment of applications by referees and independent expert assessors, visits to sites where grants will be applied to fund laboratories and house equipment and interviews of selected short-listed candidates. Membership of the Foundation’s MRAC is authorised by the National Health and Medical Research Council (NHMRC).

Each cancer scientist who sits on the MRAC is appointed on a three yearly basis, after which they may either stand down or seek re-election. For details of the Foundation’s grants procedures click here.

Our Medical Research Advisory Committee cancer scientists:

Members of the MRAC of the Australian Cancer Research Foundation:

Prof Ian Frazer

Professor Ian Frazer AC, FRS, FAA, MB, ChB (Edinburgh), MD (Melbourne)
Chairman of the ACRF Medical Research Advisory Committee

Appointed to the MRAC in 2005, Chairman since 2009. Professor, School of Medicine, The University of Queensland; Head, Cancer Immunology Program, UQDI; Board Chair, TRI Foundation; Chair, Advisory Board, Medical Research Future Fund.

Prof Mathew Vadas

Professor Mathew A Vadas AO, FAHMS, BSc, MB, BS, PhD, DSc

Appointed to the MRAC in 1997, Chairman between 1997-2007. Executive Director, Centenary Institute of Cancer Medicine & Cell Biology; Professor of Medicine, University of Sydney, Central Clinical School.

Michelle Haber

Professor Michelle Haber AM, BSc (Psych) (Hons), PhD, Hon DSc (UNSW), FAHMS

Appointed to the MRAC in 2012. Executive Director, Children’s Cancer Institute Australia, Sydney; Head of Program, Experimental Therapeutics; Conjoint Professor, Faculty of Medicine, University of NSW.


Professor Geoff Hill MBChB, MD, FRACP, FRCPA

Appointed to the MRAC in 2008. NHRMC Aust Fellow.  Head, Division of Immunology at the QIMR Berghofer Medical Research Institute, Brisbane.

Doug Hilton

Professor Doug Hilton BSc (Hons), PhD, FAA, FAHMS, FTSE, AO

Appointed to the MRAC in 2008. NHMRC Senior Principal Research Fellow. Director, Walter and Eliza Hall Institute; Head, Division of Molecular Medicine; Professor, The University of Melbourne; Member, Advisory Board, Medical Research Future Fund.

Prof Phil Hogg_cropped

Professor Philip Hogg BSc (Hons), PhD UQ

Appointed to the MRAC in 2003. NHMRC Senior Principal Research Fellow; Director, ACRF Centenary Cancer Research Centre, The Charles Perkins Centre, University of Sydney.

Prof A Lopez_cropped

Professor Angel Lopez MBBS, PhD, FRCPA, FAA

Appointed to the MRAC in 2014. Director of the Centre for Cancer Biology; Head of Division of Human Immunology, Centre for Cancer Biology, Adelaide.

Dr Roger Reddel

Professor Roger Reddel, BSc (Med), MBBS, PhD, FRACP, FAA.

Appointed to the MRAC in 2012. Director and Head, Cancer Research Unit, Children’s Medical Research Institute, Westmead Sydney; Sir Lorimer Dods Professor, Sydney University; Director Cellbank Australia.

Prof Jenny Stow 2_cropped

Professor Jennifer Stow, BSc (Hons), PhD

Appointed to the MRAC in 2009. NHMRC Principal Research Fellow; Deputy Director (Research) and Group Leader, Cell Biology and Molecular Medicine Division, Centre for Inflammation and Disease Research, Institute for Molecular Bioscience, University of Queensland.

Professor Paul Lambert

Professor Paul Lambert BS, PhD, Postdoc

Appointed to the MRAC in 2014. Howard M Termin Professor of Oncology at the University of Wisconsin; Editorial Board Member of the Journal of Virology; Director, University of Wisconsin Cancer Biology Graduate Program, and Virology Training Program.

Professor Michael Brown, Cancer researcher, cancer scientists, Australian cancer researchers

Professor Michael Brown MBBS, FRACP, FRCPA

Appointed to the MRAC in 2016. Director, Cancer Clinical Trials Unit, and Senior Consultant, Department of Medical Oncology, Royal Adelaide Hospital Cancer Centre; Clinical Professor, School of Medicine, The University of Adelaide; Affiliate Professor, School of Biological Sciences, The University of Adelaide; Adjunct Professor, School of Pharmacy and Medical Sciences, University of South Australia; Head, Translational Oncology Laboratory, Centre for Cancer Biology, SA Pathology,

Professor John Rasko, ACRF Medical Research Advisory Commitee, Cancer researchers, Australian cancer researchers

Professor John Rasko AO, BSc(Med), MBBS(Hons), PhD, FFSc(RCPA), MAICD, FRCPA, FRACP, FAHMS

Appointed to the MRAC in 2016. Research Program Leader/Principal Investigator, Centenary Institute of Cancer Medicine and Cell Biology; Director and Head of Department, Department of Cell & Molecular Therapies, Royal Prince Alfred Hospital; Senior Staff Specialist in Gene Therapy and Haematology, Sydney Cancer Centre, Royal Prince Alfred Hospital, Sydney Local Health District, Sydney; Professor, Faculty of Medicine, University of Sydney; Approved Pathology Practitioner, Genea formerly Sydney IVF.

Prof Joseph Trapani_cropped

Professor Joseph A Trapani, PhD

Appointed to the MRAC in 2007. Executive Director of Cancer Research and Head of the Cancer Immunology Program at Peter MacCallum Cancer Centre, Melbourne. Head of The Sir Peter MacCallum Department of Oncology, The University of Melbourne.

Assoc Prof Connie Trimble

Professor Connie Trimble, MD

Appointed to the MRAC in 2014. Associate Professor of Gynecology, Obstetrics and Oncology, John Hopkins School of Medicine, Baltimore, USA. Diplomat of the American Board of Pathology and the American Board of Obstetrics and Gynecology; Fellow of the American Congress of Obstetricians and Gynecologists.